GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Research & Development

Belluscura (FRA:9VQ) Research & Development : €0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Belluscura's Research & Development for the six months ended in Jun. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was €0.00 Mil.

Belluscura Research & Development Historical Data

The historical data trend for Belluscura's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Research & Development Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
- - - - -

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Belluscura Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura  (FRA:9VQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Belluscura Research & Development Related Terms

Thank you for viewing the detailed overview of Belluscura's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Research & Development
Comparable Companies
LSE:IUG LSE:IHC LSE:POLX LSE:SUN LSE:MHC LSE:DEMG LSE:RUA LSE:CREO LSE:EKF ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN
Traded in Other Exchanges
BELL:UK
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Website
https://www.belluscura.com
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines